Rob van Wijk is a principal investigator “Translational Immuno-Pharmacology” and assistant professor at the Division of Systems Pharmacology and Pharmacy at Leiden University. He graduated his PhD “Translational Pharmacokinetics-Pharmacodynamics in Zebrafish” at Leiden University early 2020, followed by two postdoctoral positions in Pharmacometrics (Uppsala University, Sweden), and Knowledge integration in anti-tuberculosis drug development (University of California, San Francisco).